Market expert SP Tulsian prefers this consumption stock

When asked about India Cement, Tulsian said, “I won’t be surprised to see the share correcting in the near term by about 15-20 percent because today it is in the upper circuit, maybe tomorrow it can go up 4-5 percent but thereafter it is risky. In fact, those who are holding it should look to exit. These stocks have run quite a lot and I won’t be surprised to see the correction coming in of about 10 percent in the next week or so.”

On HUL, he said, “If you take valuation call and after GlaxoSmithKline Consumer Healthcare merger this will be an excellent opportunity. The cash sitting on GSK is about Rs 6,000 crore at the end of this financial year, which will also get distributed by HUL amongst the shareholders and the merger will be EPS accretive. Therefore, going by valuation parameter, HUL is available at 51-52 PE multiple of FY21 – that’s the current year and after one month it will be current year earnings.”